Sign in
4

Changes in Ownership

CRESCENT BIOPHARMA, INC. Filed Acc 0001628280-26-044884

Chief Executive Officer sold 42,305 shares at $17.99 ($761,067)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Brumm Joshua T Chief Executive Officer 2026-06-22 Sale 10b5-1 −42,305 $17.99 $761,067 281,212 D
Open-market sales · 42,305 sh · avg $17.99 · $761,067
Loading xslF345X06/wk-form4_1782244898.xml…